Back

Risk of Ischemic Stroke With Beta-Blockers: Evidence From Randomized Clinical Trials

30 August 2026 (08:30 - 08:45)
Organised by: Logo
Congress Presentation Part of: Prevention in 2026: artificial intelligence, obesity and personalised cardiovascular care Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Franz Messerli

Lucerne Cantonal Hospital, Luzern (Switzerland)

5 More presentations in this session

Presentation thumbnail
The Personal Plaque Threshold: A Causal AI Biological World Model for Selecting Individualized LDL Targets to Personalize Cardiovascular Prevention
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Cardiometabolic parameters by the degree of maintenance of weight reduction in tirzepatide-treated adults with obesity: post hoc study of SURMOUNT MAINTAIN Trial
Associate Professor L. Laffin (Cleveland, US)
Slides Video
Presentation thumbnail
High-Intensity Interval Training Reduces 10-Year Mortality in Older Adults: The Generation 100 Randomized Controlled Trial
Mr S. Midttun (Trondheim, NO)
Slides Video
Presentation thumbnail
Machine learning and hemodynamic profile-based clinical decision support systems for personalized guideline-concordant antihypertensive treatment in primary care (LIGHT-precision)
Professor X. Zheng (Beijing, CN)
Slides Video
Presentation thumbnail
BetaBlocker discontinuation in patients with chronic coronary syndrome, prior myocardial infarction: a pooled analysis of the ABYSS and SMART-DECISION randomised trials.
Professor J. Silvain (Paris, FR)
Slides Video

Access the full session

Session thumbnail
Prevention in 2026: artificial intelligence, obesity and personalised cardiovascular care
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 08:30 CET
You may be interested in
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
17 November 2025
thumbnail
Webinar
Council on Stroke Webinar : Routine search for underlying cause of ischemic stroke
18 September 2018
thumbnail
Congress Presentation
Efficacy and safety of bisoprolol compared to other selective beta-1 blockers in the treatment of hypertension: a systematic review and meta-analysis of randomized parallel clinical trials
27 August 2021
thumbnail
Congress Presentation
Beta-blocker side-effects in clinical practice: a nationwide approach
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources